Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Dr. Oz and the Weight Loss Claim Controversy

January 28, 2015 5:14 pm | by Ryan Bushey, Associate Editor | Articles | Comments

A guest that has appeared on The Doctor Oz show was at the center of a lawsuit filed by the FTC. Read more...                        

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Needle Biopsies May Be Safe in Pancreatic Cancer

January 29, 2015 4:06 pm | by Cynthia Fox, Science Editor | Articles | Comments

Oncologists and patients who fear tumor needle biopsies—thinking they may cause tumor bits to break off and “seed” cancer elsewhere—may rest easier after reassuring Mayo Clinic news. Read more...                   

TOPICS:

New Biological Evidence Reveals Link Between Brain Inflammation, Depression

January 29, 2015 10:46 am | by Centre for Addiction and Mental Health | News | Comments

A new study by the Centre for Addiction and Mental Health (CAMH) found that the measure of brain inflammation in people who were experiencing clinical depression was increased by 30 percent. The findings, published today in JAMA Psychiatry, have important implications for developing new treatments for depression. Read more..

TOPICS:

Immune Cells are Ally, Not Enemy, in Battle Against Alzheimer's

January 29, 2015 10:33 am | by Yale University | News | Comments

Beta-amyloid is a sticky protein that aggregates and forms small plaques in the brains of the elderly and is thought to be a cause of Alzheimer's disease. Because specialized immune cells always surround these plaques, many have theorized that these cells are responsible for inflammation and damage to surrounding brain cells. Read more..

TOPICS:
Advertisement

New Approach to Delay Alzheimer's Onset to Be Tested

January 29, 2015 10:22 am | by Alzheimer's Drug Discovery Foundation | News | Comments

The Alzheimer's Drug Discovery Foundation (ADDF) announced a $900,000 grant to AgeneBio, a pharmaceutical company developing innovative therapies for neurologic and psychiatric diseases. Read more...                       

TOPICS:

3D Enzyme Model Provides New Tool for Drug Development

January 29, 2015 10:16 am | by UC San Diego | News | Comments

Phospholipase A2 (PLA2) enzymes are known to play a role in many inflammatory diseases, including asthma, arthritis and atherosclerosis. It then stands to reason that PLA2 inhibitors could represent a new class of anti-inflammatory medication. Read more...

TOPICS:

Arizona Monitoring Hundreds for Measles Linked to Disneyland

January 29, 2015 10:03 am | by Felicia Fonseca, Associated Press | News | Comments

A measles outbreak in Arizona that originated at California's Disney parks is at risk of increasing dramatically in size as health officials keep tabs on 1,000 people, including nearly 200 children who could have been exposed at a Phoenix-area medical center.

TOPICS:

Roche, Qualcomm to Collaborate on Remote Patient Monitoring

January 29, 2015 9:04 am | News | Comments

This is a strategic collaboration to improve remote monitoring and management of chronic disease patients. Read more...                        

TOPICS:

New Method for Identifying Aggressive Childhood Cancers

January 29, 2015 8:58 am | by Lund University | News | Comments

When a cancerous cell divides, the chromosomes often end up in the wrong place, or break and combine in incorrect ways. Read more....                     

TOPICS:
Advertisement

WHO: Ebola Response Shifts to Ending Epidemic

January 29, 2015 8:47 am | by Maria Cheng - AP Medical Writer | News | Comments

Health officials are now focused on ending the biggest-ever Ebola outbreak rather than just slowing the deadly virus' spread, the World Health Organization said Thursday. Read more...             

TOPICS:

U.S. Measles Outbreak Hits 87 Cases and Counting

January 28, 2015 12:33 pm | by Stephanie Guzowski, Editor | Articles | Comments

The measles outbreak, which originated at Disneyland, continues to expand, with 87 confirmed cases in people ranging in ages from 7 months to 70 years. Read more...                                     

TOPICS:

Swiss Drug Maker Novartis Posts Q4 Profit Drop

January 28, 2015 12:04 pm | by Associated Press | News | Comments

Swiss pharmaceutical giant Novartis AG says fourth quarter net income dropped 26 percent but the company still posted a healthy 2014 annual profit. Read more...                                 

TOPICS:

Possible Therapeutic Target for Brain Blood Vessel Disorder

January 28, 2015 11:56 am | by University of Pennsylvania | News | Comments

Tens of millions of people around the world have abnormal, leak-prone sproutings of blood vessels in the brain called cerebral cavernous malformations (CCMs). These abnormal growths can lead to seizures, strokes, hemorrhages, and other serious conditions, yet their precise molecular cause has never been determined. Read more...

TOPICS:

Drug Candidates Can Block Cell-Death Parkinson's Pathway

January 28, 2015 11:49 am | by Scripps Research Institute | News | Comments

In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown their drug candidates can target biological pathways involved in the destruction of brain cells in Parkinson's disease. Read more...

Drug Combo Suppresses Late-Stage Prostate Cancer Growth

January 28, 2015 11:37 am | by Purdue University | News | Comments

Low doses of metformin, a widely used diabetes medication, and a gene inhibitor known as BI2536 can successfully halt the growth of late-stage prostate cancer tumors, a Purdue University study finds. Read more...                          

TOPICS:

IntelliCell BioSciences Licenses Indication for Diabetes to Invigorcell

January 28, 2015 11:32 am | by IntelliCell BioSciences | News | Comments

IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company"), a regenerative medicine company utilizing adult autologous stromal vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced a license agreement for the indication of Diabetes Mellitus. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading